NASDAQ:TMDX | EBITDA Margin | TransMedics Group, Inc.

Complete source-backed ebitda margin history.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-3114.47%
2025-12-3117.88%
2025-03-3123.39%
2024-12-3111.78%
2024-03-3117.27%
2023-12-317.65%
2023-03-31-1.93%
2022-12-31-16.77%
2022-03-31-55.81%
2021-12-31-112.35%
2021-03-31-79.38%
2020-12-31-66.52%
2020-03-31-92.76%
2019-12-28-129.01%
2019-03-30-108.07%
2018-03-31-167.45%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-3122.42%
2024-12-3112.97%
2023-12-31-8.50%
2022-12-31-29.92%
2021-12-31-119.84%
2020-12-31-87.48%
2019-12-28-109.82%
2018-12-29-132.82%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.